Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation …
Purpose To evaluate the risk of locoregional recurrence (LRR) associated with locoregional
treatment of women with primary breast cancer tumors negative for estrogen receptor …
treatment of women with primary breast cancer tumors negative for estrogen receptor …
[HTML][HTML] TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy
Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with
a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target …
a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target …
Triple‐negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity
F Lara‐Medina, V Pérez‐Sánchez… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Triple‐negative breast cancer (TNBC) is defined as breast cancer that is
negative for estrogen receptor, progesterone receptor, and human epidermal growth factor …
negative for estrogen receptor, progesterone receptor, and human epidermal growth factor …
Update on triple-negative breast cancer: prognosis and management strategies
Triple negative breast cancer (TNBC) is a heterogeneous disease comprehending different
orphan breast cancers simply defined by the absence of ER/PR/HER-2. Approximately 15 …
orphan breast cancers simply defined by the absence of ER/PR/HER-2. Approximately 15 …